Tatyana Kushner1, Catherine A Chappell2, Arthur Y Kim3. 1. Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1123, New York, NY, 10029. 2. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, 300 Halket Street, Pittsburgh, PA 15206. 3. Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street Cox 6, Boston, MA 02114.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to discuss the reasons for HCV testing during pregnancy and to review what is known about antiviral treatment during pregnancy. RECENT FINDINGS: Hepatitis C virus affects over 3 million persons in the United States and is one of the leading infectious causes of death. While HCV is most commonly transmitted via parenteral exposures, thus affecting people who inject drugs, it is also transmitted from mother-to-child. Due to an expanding opioid crisis, an increasing number of women of childbearing age are now infected, resulting in transmission to infants. Risk-based screening has never been proven effective and thus universal screening of pregnant women for HCV infection has been recommended. SUMMARY: Obstetricians may play a key role in the U.S. by implementing universal testing for HCV in pregnant women, thereby enhancing the health of mothers and identifying children at risk.
PURPOSE OF REVIEW: The purpose of this review is to discuss the reasons for HCV testing during pregnancy and to review what is known about antiviral treatment during pregnancy. RECENT FINDINGS: Hepatitis C virus affects over 3 million persons in the United States and is one of the leading infectious causes of death. While HCV is most commonly transmitted via parenteral exposures, thus affecting people who inject drugs, it is also transmitted from mother-to-child. Due to an expanding opioid crisis, an increasing number of women of childbearing age are now infected, resulting in transmission to infants. Risk-based screening has never been proven effective and thus universal screening of pregnant women for HCV infection has been recommended. SUMMARY: Obstetricians may play a key role in the U.S. by implementing universal testing for HCV in pregnant women, thereby enhancing the health of mothers and identifying children at risk.
Entities:
Keywords:
antiviral treatment; hepatitis C virus; perinatal transmission; pregnancy; testing
Authors: Line Modin; Adam Arshad; Bryony Wilkes; Jennifer Benselin; Carla Lloyd; William L Irving; Deirdre A Kelly Journal: J Hepatol Date: 2018-11-27 Impact factor: 25.083
Authors: Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg Journal: Clin Infect Dis Date: 2014-08-11 Impact factor: 9.079
Authors: Danica E Kuncio; E Claire Newbern; Marcelo H Fernandez-Viña; Bruce Herdman; Caroline C Johnson; Kendra M Viner Journal: J Urban Health Date: 2015-04 Impact factor: 3.671
Authors: Stephen W Patrick; Audrey M Bauer; Michael D Warren; Timothy F Jones; Carolyn Wester Journal: MMWR Morb Mortal Wkly Rep Date: 2017-05-12 Impact factor: 17.586